View in EDS HTML Full Text PDF Full Text

A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions.

Saved in:
Bibliographic Details
Title: A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions.
Authors: Donzelli, Sara1 (AUTHOR), Cioce, Mario2,3 (AUTHOR), Sacconi, Andrea4 (AUTHOR), Zanconato, Francesca5 (AUTHOR), Daralioti, Theodora6 (AUTHOR), Goeman, Frauke7 (AUTHOR), Orlandi, Giulia8 (AUTHOR), Di Martino, Simona9 (AUTHOR), Fazio, Vito Michele2,3,10 (AUTHOR), Alessandrini, Gabriele11 (AUTHOR), Telera, Stefano12 (AUTHOR), Carosi, Mariantonia6 (AUTHOR), Ciliberto, Gennaro13 (AUTHOR), Botti, Claudio14 (AUTHOR), Strano, Sabrina7 (AUTHOR), Piccolo, Stefano5,15 (AUTHOR), Blandino, Giovanni1 (AUTHOR) giovanni.blandino@ifo.it
Source: Molecular Cancer. 7/22/2022, Vol. 21 Issue 1, p1-7. 7p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14764598
DOI:10.1186/s12943-022-01617-6